If you keep up with health news, you're probably familiar with GLP-1 agonists like Wegovy and Ozempic . But what you may not know is that these 'miracle drugs' can come with extreme side effects that have lifelong impacts. You also may not realize that 81% of Ozempic and Wegovy users are women – so even if you're not taking a GLP-1 agonist, you may know someone who is, and this is important for you to hear. Ozepmic and Wegovy are produced by pharmaceutical giant Novo Nordisk and, within the last few years, have become FDA-approved in the treatment of type 2 diabetes and obesity, respectively.
https://www.eviemagazine.com/post/ozempic-regret-is-rising-i-wish-i-never-touched-it#eviemagazine
Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.